Vertex secures Health Canada approval for expanded use of KALYDECO

02:48 EST 29 Jan 2019 | Pharmaceutical Business Review

“We believe it is important to treat the underlying cause of cystic fibrosis as early as possible, and are pleased that parents and physicians now have a medicine

The post Vertex secures Health Canada approval for expanded use of KALYDECO appeared first on Pharmaceutical Business review.

Original Article: Vertex secures Health Canada approval for expanded use of KALYDECO

More From BioPortfolio on "Vertex secures Health Canada approval for expanded use of KALYDECO"